Trademark Overview
On Monday, July 1, 2024, a trademark application was filed for TANKA with the United States Patent and Trademark Office. The USPTO has given the TANKA trademark a serial number of 98626861. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 1, 2024. This trademark is owned by Sanofi. The TANKA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of rare diseases, rare blood disorders, and oncologic, immunologic, and neurologic diseases and disorders; monoclonal and polyclonal antibodies for medical purposes; diagnostic preparations for medical and veterinary use; biological tissue cultures for medical and veterinary use
Scientific research and laboratory research services in the field of biotechnology; biological and pharmaceutical research; biotechnical research; advice being consulting services in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and new component products for third parties, medical and scientific research, namely, conducting clinical trials for others; chemical analysis and research services; medical research; pharmaceutical research services.